ArticleBMC research notes2026
High concordance of malignant tissue across ultrasound-guided transvaginal tru-cut biopsy cores of ovarian lesions: a prospective feasibility study.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveUltrasound-guided transvaginal tru-cut biopsy is used for histological confirmation of ovarian malignancy in selected clinical settings. Although multiple cores are routinely obtained to improve diagnostic yield, the distribution of malignant tissue across cores obtained during a single biopsy session has not been systematically evaluated. This question is particularly relevant for translational workflows, such as tissue cryopreservation, where histological verification of each individual core is impractical. We present a prospective feasibility study evaluating intra-procedural concordance of malignant tissue across ultrasound-guided transvaginal tru-cut biopsy cores of ovarian lesions.
resultsTwenty-one patients undergoing ultrasound-guided transvaginal tru-cut biopsy of ovarian lesions were included in the final analysis. Tru-cut biopsy yielded a diagnostic result in 20 of 21 procedures (95.2%; Wilson 95% confidence interval 78.1%-99.4%). In all biopsy procedures in which malignant tissue was identified in at least one core, malignant tissue was consistently present in all other evaluable cores obtained during the same session, with no discordant cases observed. When tissue fragments were present, malignant tissue was also consistently identified in fragments whenever malignant tissue was present in cores. One procedure, involving a mucinous adenocarcinoma arising in the background of a borderline tumor, yielded no malignant in any submitted material. Overall, these findings demonstrate a high degree of intra-procedural concordance of malignant tissue across biopsy cores and support the feasibility of biopsy workflows relying on confirmation of malignant tissue in a single core.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.